CORONAVIRUS VACCINE TRACKER

• The packed dormitories housing the foreign labourers were the biggest infection clusters during the peak of the covid-19 outbreak in the island last year

• Health officials had been investigating the deaths of eight people with underlying conditions who had adverse reactions after receiving AstraZeneca's COVID-19 vaccine

• People receiving the letters are invited to go online to the national booking service to arrange a jab at a time and location that is convenient for them

• This is the first single-dose Covid-19 vaccine to be authorized in Canada, and has been cleared for use by people over 18 years of age
• Ottawa has ordered up to 38 million doses

• The Central Drugs Standard Control Organisation will review the data
• An expert panel will review the data for granting the vaccine emergency use authorization

• Most the shortfall is because AstraZeneca has pledged 'best reasonable efforts' to deliver around 100 million doses in that time, but is now on track to supply just 40% of that

• Germany, Italy and other large European countries are restricting older people from receiving the shot as France loosens rules

• With governments looking to turbocharge production of Covid vaccines, officials are learning that making more lipids isn’t so easy

• Merck received full results from OncoImmune’s late-stage study that were consistent with the earlier, positive results

• J&J’s vaccine was authorized for US use on Saturday, adding a third shot to the country’s mass inoculation efforts
• Assistant Press Secretary Kevin Munoz said via Twitter that Biden would announce the 'historic partnership'

• The first phase witnessed apparent hesitancy and thereby low uptake of the covid-19 vaccines among healthcare and frontline workers
• Total 4,27,072 vaccine doses were given till 7 pm today, the 45th day of nationwide covid-19 inoculation program

• China's first Ad5-nCoV COVID-19 vaccine was rolled out on Friday
• Phase-I clinical trials of the vaccine started on March 16, last year, making it the world's first COVID-19 candidate vaccine that entered clinical trials, the report claims

If a variant with a mutated spike protein crops up that the original vaccine can't recognize, companies would swap out that piece of genetic code for a better match — if and when regulators decide that's necessary

• Biden administration officials have said US expects J&J to release 3 million to 4 million shots next week, assuming it’s authorized for use
• Johnson & Johnson’s vaccine was 72% effective in the U.S.-based portion of a global study that enrolled more than 43,000 people

• Registrations of the next phase of India's Covid-19 vaccination is slated to begin from 1 March
• The total number of vaccination crossed 1.30 crores in the country, Union Health Ministry said

• The two vaccines are made by CanSino Biologics Inc and Sinopharm's affiliate Wuhan Institute of Biological Product

• No-fault compensation may cover 97 million Covishield doses expected to be distributed in India through Covax

• Bharat Biotech Chairman Krishna Ella said his company would mainly need data from ICMR or WHO on the genetic sequence of any variant to quickly make an effective vaccine
• Biological E. Managing Director Mahima Datla said there was no need to be 'overly concerned' about the mutations

Serum Institute, the world's biggest vaccine maker by volume, on Sunday asked for patience from foreign governments awaiting their supply of Covid-19 shots, saying it had been directed to prioritise India's requirements

• Six of the vaccines are in the third stage of the trials, which is one of the last phases
• China has already given conditional approval to two inactivated COVID-19 vaccines made by state-owned developers -- Sinopharm and Sinovac Biotech